--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About ABCL20260220C4
Biological Technology
AbCellera Biologics Inc., was incorporated and commenced business activities on November 8, 2012 under the British Columbia Business Companies Act. The company is engaged in the business of combining a variety of complex technologies in its medical research and development to discover antibody drugs faster, cheaper and more efficiently. Since its inception, the company has been committed to R&D activities to support its current partner projects and future platform development efforts.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
